ARCHIVES

In Brief: FDA Opens Advisory Committee Consideration Of NDAs, Finds Discussion Is Not Inhibited

This article is from The Cancer Letter archive.

Vol. 02 No. 37 | September 10, 1976

Download PDF Visit The Full Archive

Related Articles

DCT Issues New Program Announcement On Clinical Research

December 5, 1980

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

July 28, 2006

ONS, ASCO, AACR Growth Surge Continues; Flex Political Muscles During DC Meetings

June 8, 1990

IOM Committee Will Probe Duke Scandal Together With Other “Omics” Case Studies

January 7, 2011

NCI Reorganization Proposals Create opposition Among Some Advisors

June 17, 1988

Senate Committee Blocks Effort To Overturn Organ Systems Changes

December 10, 1982